Dendritic cells: at the clinical crossroads - PubMed (original) (raw)
Comment
Dendritic cells: at the clinical crossroads
J J Mulé. J Clin Invest. 2000 Mar.
No abstract available
Comment on
- Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopes.
Dhodapkar MV, Krasovsky J, Steinman RM, Bhardwaj N. Dhodapkar MV, et al. J Clin Invest. 2000 Mar;105(6):R9-R14. doi: 10.1172/JCI9051. J Clin Invest. 2000. PMID: 10727452 Free PMC article.
Similar articles
- Dendritic cell-based vaccines: clinical applications in breast cancer.
Gelao L, Criscitiello C, Esposito A, De Laurentiis M, Fumagalli L, Locatelli MA, Minchella I, Santangelo M, De Placido S, Goldhirsch A, Curigliano G. Gelao L, et al. Immunotherapy. 2014;6(3):349-60. doi: 10.2217/imt.13.169. Immunotherapy. 2014. PMID: 24762078 Review. - Characterization of tumour infiltrating lymphocytes in human breast cancer.
Chin Y, Janssens J, Bleus J, Vandepitte J, Vandenbrande J, Raus J. Chin Y, et al. Eur J Cancer Prev. 1993 Nov;2 Suppl 3:27-31. Eur J Cancer Prev. 1993. PMID: 8298448 No abstract available. - The antigen-presenting activities of Ia+ dendritic cells shift dynamically from lung to lymph node after an airway challenge with soluble antigen.
Xia W, Pinto CE, Kradin RL. Xia W, et al. J Exp Med. 1995 Apr 1;181(4):1275-83. doi: 10.1084/jem.181.4.1275. J Exp Med. 1995. PMID: 7699319 Free PMC article. - Shaping naive and memory CD8+ T cell responses in pathogen infections through antigen presentation.
Belz GT, Wilson NS, Kupresanin F, Mount AM, Smith CM. Belz GT, et al. Adv Exp Med Biol. 2007;590:31-42. doi: 10.1007/978-0-387-34814-8_2. Adv Exp Med Biol. 2007. PMID: 17191375 Review. No abstract available.
Cited by
- Gold-Nanostar-Chitosan-Mediated Delivery of SARS-CoV-2 DNA Vaccine for Respiratory Mucosal Immunization: Development and Proof-of-Principle.
Kumar US, Afjei R, Ferrara K, Massoud TF, Paulmurugan R. Kumar US, et al. ACS Nano. 2021 Nov 23;15(11):17582-17601. doi: 10.1021/acsnano.1c05002. Epub 2021 Oct 27. ACS Nano. 2021. PMID: 34705425 Free PMC article. - Specifically activated dendritic cells--cell-based vaccine against lymphosarcoma exhibiting multiple drug resistance phenotype.
Mironova NL, Panzinskyi EE, Popova NA, Nikolin VP, Zenkova MA, Vlasov VV. Mironova NL, et al. Dokl Biochem Biophys. 2009 Sep-Oct;428:252-6. doi: 10.1134/s1607672909050081. Dokl Biochem Biophys. 2009. PMID: 20848912 No abstract available. - Targeting MARCO can lead to enhanced dendritic cell motility and anti-melanoma activity.
Matsushita N, Komine H, Grolleau-Julius A, Pilon-Thomas S, Mulé JJ. Matsushita N, et al. Cancer Immunol Immunother. 2010 Jun;59(6):875-84. doi: 10.1007/s00262-009-0813-5. Epub 2010 Jan 8. Cancer Immunol Immunother. 2010. PMID: 20054688 Free PMC article. - Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J, Wells JW, Darling D, Harrison P, Farzaneh F. Galea-Lauri J, et al. Cancer Immunol Immunother. 2004 Nov;53(11):963-77. doi: 10.1007/s00262-004-0542-8. Epub 2004 May 14. Cancer Immunol Immunother. 2004. PMID: 15146294 Free PMC article. - Immunological weapons against acute myeloid leukaemia.
Galea-Lauri J. Galea-Lauri J. Immunology. 2002 Sep;107(1):20-7. doi: 10.1046/j.1365-2567.2002.01497.x. Immunology. 2002. PMID: 12225359 Free PMC article. Review.
References
- Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245–252. - PubMed
- Randolph GJ, et al. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity. 1999;11:753–761. - PubMed
- Labeur MS, et al. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J Immunol. 1999;162:168–175. - PubMed